valsartan has been researched along with Atrial Remodeling in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, CY; Deng, H; Fang, Y; Kuang, SJ; Li, LA; Li, Q; Li, QQ; Liu, Y; Peng, DW; Rao, F; Wei, W; Wu, SL; Xue, YM; Yang, H; Zeng, P; Zhang, MZ; Zhang, QH | 1 |
| Deng, CY; Guo, HM; Li, X; Liu, FZ; Liu, Y; Rao, F; Wang, ZY; Wei, W; Wu, SL; Xue, YM; Yang, H; Zhang, MZ | 1 |
| Chen, Q; Li, D; Lu, C; Wang, Y; Xu, T; Zhou, R | 1 |
| Chang, JP; Chang, TH; Chen, MC; Ho, WC; Hsiao, CC; Hsu, SD; Huang, HD; Liu, WH; Wang, FS | 1 |
| Chen, JH; Chen, LL; Chen, XH; Fu, FY; Tang, MR; Wang, WW; Zhang, FL | 1 |
1 review(s) available for valsartan and Atrial Remodeling
| Article | Year |
|---|---|
Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Remodeling; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Ventricular Remodeling; Walk Test | 2019 |
4 other study(ies) available for valsartan and Atrial Remodeling
| Article | Year |
|---|---|
Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats.
Topics: Aminobutyrates; Angiotensins; Animals; Antihypertensive Agents; Atrial Fibrillation; Atrial Remodeling; Biphenyl Compounds; Drug Combinations; Hypertension; Neprilysin; Rats; Rats, Inbred SHR; Tetrazoles; Valsartan | 2023 |
High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Atrial Remodeling; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Hydrostatic Pressure; Mice; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; src-Family Kinases; Up-Regulation; Valsartan | 2020 |
Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expression profiling analysis: role of type I angiotensin II receptor antagonist.
Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Remodeling; Down-Regulation; Female; Gene Expression Profiling; Heart Atria; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Renin-Angiotensin System; Swine; Swine, Miniature; Tetrazoles; Translational Research, Biomedical; Up-Regulation; Valine; Valsartan | 2015 |
Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Apoptosis; Arrhythmias, Cardiac; Atrial Remodeling; Benzimidazoles; Benzoates; Blood Pressure; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Heart Rate; Hypertension; Male; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; ras Proteins; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Telmisartan; Time Factors; Valsartan | 2015 |